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Background and objectives:  
Low cardiorespiratory ﬁtness (CRF) is a signiﬁcant predictor of cardiovascular disease (CVD). Exercise 
interventions increase CRF and reduce CVD risk. A specific exercise prescription coming from the results of 
CRF tests, aims to optimize the beneficial results of exercising, provided that patients reach their 
cardiorespiratory limitations during the CRF test. However, this has never been investigated in rheumatoid 
arthritis (RA). The aim of this study was to investigate if patients with RA can achieve well-established criteria 
during CRF testing.   
Methods: 
 105 patients with RA were evaluated for age, gender, height, weight, and body mass index (BMI) 
and CRF. CRF was determined on the basis of maximal oxygen uptake (VO2max) using a calibrated breath-by-
breath system. The criteria used to determine CRF were: a) VO2 plateau, b) respiratory exchange ratio (RER) 
> 1.1 and c) achieved maximum predicted heart rate (220-age). Al participants were assessed at baseline the 
CRF capacity (VO2MAX), Disease Activity Score 28 (DAS28) and Disease Severity (HAQ). 
Results:  
Only 26.6% of the patients achieved the VO2max test criteria. More specifically, 4.7% of patients 
reached a VO2 plateau. The RER ratio was reached by 78% of the patients while HRmax was achieved by 
27.6% of the studied patients. Between the two groups, i.e. those who met the VO2max criteria and those 
who did not, we found that there were no significant differences in DAS 28 (p>0.05) and BMI (p>0.05). 
However, HAQ (p=0.04) was significantly improved in the patients who achieved VO2max.  
Conclusion:  
Approximately 1/4 of the patients with RA completed the CRF testing as they met the VO2max 
criteria. It seems that other reasons are responsible for terminating a CRF test in RA patients. Our results 
suggest that this may be due to the overall physical disability (HAQ) caused by the disease. 
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Εισαγωγή και στόχοι:  
Τα χαμηλά επίπεδα καρδιοαναπνευστικής ικανότητας αποτελούν ένα σημαντικό προγνωστικό 
παράγοντα καρδιαγγειακών παθήσεων . Οι ασκησιογενείς παρεμβάσεις αυξάνουν την καρδιοαναπνευστική 
ικανότητα και μειώνουν τον κίνδυνο καρδιαγγειακής νόσου. Η συνταγογράφηση της άσκησης που 
προέρχεται από τα αποτελέσματα αξιολόγησης της καρδιοαναπνευστικής ικανότητας , έχει ως στόχο την 
βελτιστοποίηση των ευεργετικών αξιών της άσκησης, υπό την προϋπόθεση ότι οι ασθενείς πληρούν τα 
κριτήρια μέγιστης καρδιοαναπνευστικής ικανότητας κατά την διάρκεια αξιολόγησης της μέσω του τεστ 
κοπώσεως. Ωστόσο, αυτό δεν έχει διερευνηθεί έως τώρα σε ασθενείς με ρευματοειδή αρθρίτιδα (ΡΑ). Ο 
σκοπός της παρούσας μελέτης ήταν να μελετήσει εάν οι ασθενείς με ΡΑ επιτυγχάνουν τα καθορισμένα 
κριτήρια κατά τη διάρκεια του τεστ κοπώσεως. 
Μεθοδολογία:  
105 ασθενείς με ΡΑ αξιολογήθηκαν για την ηλικία, το φύλο, το ύψος, το βάρος, και δείκτη μάζας 
σώματος σε σχέση με την CRF. Η καρδιοαναπνευστική ικανότητα προσδιορίστηκε βάσει της μέγιστης 
πρόσληψης οξυγόνου (VO2max) χρησιμοποιώντας ένα βαθμονομημένο σύστημα ανάλησης των 
παραγόμενων προϊόντων του κύκλου της αναπνευστικής διαδικασίας. Τα κριτήρια που χρησιμοποιήθηκαν 
για τον προσδιορισμό της CRF ήταν: α) VO2 plateau, β) RER (αναπνευστικό πηλίκο) > 1.1 και γ) επίτευξη της 
μέγιστης προβλεπόμενης καρδιακής συχνότητας (220-ηλικία). Τα αποτελέσματα αφορούν τις αρχικές 
μετρήσεις όλων των συμμετεχόντων ως προς την αξιολόγηση της καρδιοαναπνευστικής ικανότητας 
(VO2max), Δραστηριότητας της Νόσου (DAS28) και Βαρύτητας της Νόσου (HAQ). 
Αποτελέσματα:  
Μόνο το 26,6% κατάφερε να φθάσει τα όρια που τέθηκαν για μια εκτίμηση  VO2max σε ασθενείς με 
ΡΑ. Συγκεκριμένα, το 4,7% των ασθενών έφτασε σε VO2 plateau, ο δείκτης RER επιτεύχθηκε από το 78% των 
ασθενών, ενώ η μέγιστη προβλεπόμενη καρδιακή συχνότητα (HRmax) επιτεύχθηκε κατά 27,6% των 
ασθενών που μελετήθηκαν. Μεταξύ των δύο ομάδων, δηλαδή εκείνων που πληρούσαν τα κριτήρια της 
VO2max και εκείνων που δεν τα πληρούσαν, διαπιστώσαμε ότι δεν υπήρχαν στατιστικά σημαντικές 
Institutional Repository - Library & Information Centre - University of Thessaly




διαφορές στην DAS 28 (p> 0.05) και BMI (p> 0.05). Αντιθέτως, η ομάδα των ασθενών που εκπλήρωσαν τα 
κριτήρια της VO2max, είχαν καλύτερα αποτελέσματα στην αξιολόγηση HAQ (p = 0.04).  
Συμπέρασμα:  
Το ένα τέταρτο των ασθενών με RA σταμάτησε το τεστ κοπώσεως λόγω των κριτηρίων της VO2max. 
Φαίνεται ότι και άλλοι λόγοι είναι υπεύθυνοι για τον τερματισμό τoυ τεστ κοπώσεως στους ασθενείς με RA. 
Τα αποτελέσματά μας δείχνουν ότι αυτό μπορεί να οφείλεται στην συνολική σωματική ανικανότητα (HAQ) 
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RA is the most common type of chronic Inflammatory Arthritis and an Autoimmune Disease. This 
results not only in joint destruction and functional disability but also in systemic manifestations such as 
increased body fatness, loss of muscle mass, hyper metabolism and increased risk for CVD, which is 
significantly higher in RA patients compared to normal population (1). It is well stated in current literature 
that physical inactivity (2),  vascular dysfunction (3–5) and obesity (6,7) are independent  CVD factors. Yet, 
the factors that lead to this phenomenon are not well defined. It has been shown, that individualised aerobic 
and resistance exercise in RA patients, significantly improves endothelial function in different vascular beds 
and reverses the unfavorable cardiovascular risk seen in RA (3)(8). Therefore, exercise may be crucial for the 
prevention of classical and novel CVD risk factors in RA patients and is associated with significant 
improvements in cardiorespiratory fitness (CRF), an independent CVD disease risk factor (1–4,8–10). 
In order to improve CRF, patients need to increase their level of physical activity. However, due to 
disease manifestations, patients with RA refrain from exercising as they think by doing so, it may exacerbate 
the disease’s symptoms. This unfounded belief is reinforced by the rheumatology health professionals that 
advice patients not to exercise. As such, it is not a surprise that the literature consistently shows that RA 
patients lead a sedentary lifestyle in comparison with age and gender matched controls. In contrast, 2 
systematic reviews and metanalyses from the Cochrane Library reveal that exercise is safe for RA patients 
and may reverse the diseases’ symptoms. As such, exercise should be a fundamental part of managing the 
disease.  
In order to set the intensity of exercise to the correct level, patients need to perform a VO2max test 
in order to identify their maximum heart rate. This information is then used to develop an effective exercise 
prescription. However, patients with RA may stop CRF testing due to functional limitations and not volitional 
exhaustion. Volitional exhaustion is determined by specific criteria that are: plateau, maximum heart rate 
and respiratory exchange ratio. This is crucial information in order to develop the best possible exercise 
prescription. Currently, there are no studies that have investigated whether patients with RA stop CRF 
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testing due to cardiorespiratory limitations using the aforementioned criteria. As such, the aim of the 
present study was to assess for the first time the established CRF criteria in RA.    
2. Aims 
The aim of this study is to evaluate the established criteria of a successful maximal CRF test in 
patients with RA. This can lead to an optimization of the exercise prescription in order to minimize the 
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3. Literature Review 
3.1. Rheumatoid Arthritis (RA) 
3.1.1. History and Definition 
It is very probable that rheumatoid arthritis appeared thousands of years ago in early Native 
American populations, but until the 17th century, it had not occurred in Europe (11). RA is a chronic, 
symmetrical, polyarticular, and systemic inflammatory disease that mainly affects the synovial membrane of 
the small joints of the hands and feet (11). Even though the aggressive form of tissue called pannus damages 
local articular structures apart from synovial inflammation and hyperplasia (“swelling”), which is the joint 
lining, autoantibody production (rheumatoid factor and anticitrullinated protein antibody [ACPA]), cartilage 
destruction, bone destruction (“deformity”) and systemic characteristics, contain cardiovascular, pulmonary, 
psychological, and skeletal disorders (12,13). It is the most common inflammatory rheumatic disease that 
can lead to long-term functional inability and disability (11). Long-term prognosis is not considered good for 
the treatment of disease: 80%of patients suffering from RA are disabled after 20 years (10), and life 
expectancy has fallen by an average of 3-18 years.  (15)   
3.2. Pathophysiology of RA 
From the explanatory side, it seems that many factors, such as environmental, genetic, hormonal 
and immunological, are involved in the pathogenesis of the disease, but the exact cause is not known (16) . 
Questions vary as which genetic-environmental factors cause autoimmunity and why does that spawn 
articular localization? Furthermore, why is synovial inflammation prolonged, leading to local destruction and 
joint dysfunction? Additionally, in patients with rheumatoid arthritis what is the cause that leads to systemic 
disease (13). 
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3.3. Pathogenesis of RA 
3.3.1. Genetic Factors 
It is well documented that there is a genetic predisposition regarding the development of 
rheumatoid arthritis. Genome wide analyses confirm that the immune regulatory factors form the basis of 
the disease (13). It has been found that the prevalence of the disease is higher in RA patients who are 
positive for rheumatoid factor or ACPA and leukocyte antigen (HLA)-DRB1 alleles (17). These results show 
that some predisposing T-cell repertoire selection, antigen presentation, or a change in peptide affinity, play 
a role in promoting auto reactive adaptive immune responses (13). Moreover, a potential pro-inflammatory 
signaling function contains molecular mimicry of the shared epitope by microbial proteins. The increased T-
cell senescence is induced by a shared epitope containing HLA molecules (18,19). Furthermore, another 
potential pathway for RA pathogenesis is the nuclear factor κB (NF-κB) that implicates dependent signaling 
and T-cell stimulation, activation, and functional differentiation. Other identified risk alleles in ACPA- positive 
rheumatoid arthritis consistently aggregate functionally with immune regulation (20–23). Finally, genetic risk 
factors for ACPA-positive diseases are considered more significant than ACPA-negative diseases and patients 
with ACPA-negative disease have a more propitious prognosis than those with ACPA-positive disease (13).  
3.3.2. Environmental Factors 
Regarding the effects of gene-environment, smoking and other types of bronchial stress (e.g., 
exposure to silica) increase the risk of RA among individuals delicate to HLA-DR4 alleles (24). Furthermore, 
the combination of smoking and HLA-DRB1 alleles increase a person's risk to present ACPA (25).  
3.3.3. Infectious Related Agents with RA 
Viruses such as Epstein–Barr, cytomegalovirus, proteus species, and Escherichia coli and their by-
products (e.g., heat-shock proteins) have also been linked in experimental studies with the development of 
RA (26,27). The immune system triggering may be caused by the induction of a rheumatoid factor and a 
high-affinity autoantibody against the Fc portion of immunoglobulin, which has been used for a long time as 
Institutional Repository - Library & Information Centre - University of Thessaly




a diagnostic pointer of RA and it is involved in its pathogenesis. Finally, RA seems to be linked with 
periodontal disease (28) and gastrointestinal microbiome (29).  
3.3.4. RA and the Nervous System 
It is accepted that a connection exists between the hypothalamus-pituitary-adrenal axis and cytokine 
production, which is the starting point of RA (30). The molecular explanations for such phenomena come 
from animal models of inflammation (30). The central nervous system is usually associated with immune 
regulation and homeostasis. In addition, neuroimmune logic effects modulate disease growth in rodent 
models with arthritis. These kind of influences might function locally (some neurotransmitters are called 
synovitis in RA) or centrally (cytokines are quickly up-regulated in the hypothalamus during peripheral 
inflammation) (31). 
3.3.5. Synovial Immunologic Processes and Inflammation 
The micro environmental modifications resulting to Synovitis at RA happens when leukocytes enter 
the synovial compartment and cause profound synovial architectural reorganization and local fibroblast 
activation. Leukocyte gathering mainly indicates migration instead of local proliferation as a consequence of 
neo-angiogenesis, which occurs by local hypoxic conditions and cytokines (32,33). 
3.3.5.1. Adaptive Immune Pathways 
Humoral adaptive immunity is inseparable to RA (13). Great importance is given to the role of type 
17 helper T cells (Th17), that creates interleukin-17A, 17F, 21, and 22 and tumor necrosis factor α (TNF-α) 
(33,34). RA is traditionally thought to be a disease caused by type 1 helper T cells (34,35). The macrophage-
derived and dendritic-cell–derived transforming growth factor β as well as interleukin-1β, -6, -21, and -23 
offer an environment that supports Th17 differentiation and efface differentiation of regulatory T cells, 
shifting T-cell homeostasis toward inflammation (36). Other clinical remarks support the role of B cells and 
their progeny in the pathogenesis of RA to contain auto antigen and cytokine production (e.g., interleukin-6, 
TNF-α) (13). 
Institutional Repository - Library & Information Centre - University of Thessaly




3.3.5.2. Cytokines and Intracellular Signalling Pathways 
After the successful therapeutic blockage of the membrane, the soluble and the receptor in patients 
with RA of the two cytokines, the importance of TNF-α and interleukin-6 was established (13). They play 
crucial roles in the aggravation of RA, although IL-1, VEGF and probably IL-17 also play a significant influence 
on the development of the disease (37). These cytokines, through complex mechanisms, activate genes 
responsible for inflammatory reactions (37). TNF-α is very important for the activation of cytokines, the 
expression of chemokines, the expression of molecules for attachment to the endothelial cells, the 
prevention of synovial fibroblasts, the contribution to the production of angiogenesis and the feeling of pain, 
as well as the suppression of regulatory T-cells (38). Respectively, IL-6 activates the local production of 
leukocytes and autoantibodies, as well as mediating the body's response during acute systemic reactions of 
the body in cases such as anaemia, cognitive dysfunction, and lipid-metabolism dysregulation (13). 
Regarding IL-1, although strongly expressed in RA, when assessing the affect it has on leukocytes, endothelial 
cells, chondrocytes  and osteoclasts, the clinical benefits upon inhibition are moderate. This result, which is a 
paradox as it is exactly the opposite of what one would expect, is under investigation (39) (40). Other 
cytokines, such as the IL-17, which is allegedly involved intensely in the pathogenesis of inflammatory and 
autoimmune diseases, including RA, have the important role of secreting a CD4-cell subset in synovitis      
(41–43).  
3.3.6. Cartilage Damage 
Cartilage destruction in RA occurs when the cytokines TNF- a, IL-1 and IL-6 trigger synoviocytes, 
resulting in the secretion of matrix metalloproteinases (MMPs) in scatter factor (SF). Also, chondrocytes will 
immediate the release of additional MMPs in the cartilage (16,44).  Endogenous enzyme inhibitors, such as 
tissue inhibitors of TIMPs, fail to reverse these processes; articular cartilage has limited regenerative 
capacity, while the cartilage is gradually deprived chondrocytes, which undergo apoptosis. All this will 
eventually lead to the destruction of the cartilage (13). 
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3.3.7. Bone Erosion 
80% of patients newly diagnosed with RA, develop bone erosion associated with chronic and 
extended inflammation (45,46). The articular cytokines, mainly the macrophage-stimulating factor and 
receptor activation of NF-kB, promote osteoclast differentiation and invasion of the surface of the 
periosteal, adjacent to the articular cartilage (47). Osteoclasts are multinucleated cells generated from 
mononuclear compound ancestors belonging to the family of monocytes or macrophages (48).  
RA is caused by mediators such as cytokine Dickkopf-1 and frizzled protein 1 associated with the 
inhibition of differentiation of the mesenchymal precursors into chondroblasts and osteoblasts (49). 
Mesenchymal stem cells, which can differentiate into adipocytes, chondrocytes and osteoblasts can be 
detected in the synovial (50,51). Nonetheless, their biological characteristics and the effect of local 
inflammation in their properties remains unknown (13). All these provide little evidence of the treatment of 
RA, in contrast to other chronic inflammatory arthropathies (49).  
3.3.8. Systemic Consequences of Rheumatoid Arthritis 
The relationship between CVD in patients with RA is well established and demonstrates that it is 
more than three times possible to occur compared to the general population, but this is not explain the 
increased prevalence of well-established risk factors (52). Specifically, the CVD related mortality rate is 
higher and RA patients are more likely to die from myocardial infarction, stroke, and heart failure (53–55). 
All this happens because of the connection of RA with pro-atherogenic complex changes which results in a 
systemic inflammation (56), which share the same biological pathways with atherosclerosis. This metabolic 
pathway leads to the release of cytokines TNF- a, IL-6 and IL-1 from synovial tissue, and causes widespread 
dysfunction altering the function of adipose tissue, skeletal muscle, liver and vascular endothelium (56), 
called collectively “inflammatory metabolic syndrome” (57,58). This, in turn, leads to insulin resistance, 
increased global oxidative activity and the relation of RA with dyslipidaemia which is characterized by low 
overall and high density lipoprotein (HDL), cholesterol, elevated triglycerides, lipoprotein levels and an 
increase in small, low-density lipoprotein species (LDL) (56). Although the reduction of inflammation in 
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patients with severe RA after treatment through the use of a biological agents can result in elevated levels of 
total HDL and LDL cholesterol (and probably triglyceride), but the reduction of inflammation, nevertheless, 
reduces the risk of CVD (59) . In addition, studies have shown that elevated levels of interferon 
concentration of IL - 6 in plasma, typical of patients with RA, cause potentiall detrimental cardiovascular 
symptoms such as myocardial infarction (60). Furthermore, prolonged inflammation in RA patients also 
affects the brain, causing fatigue and decreased cognitive function while also affecting the lungs through the 
induction of inflammatory and fibrotic disease. Moreover, it affects the liver through increased acute phase 
response and chronic anaemia. Finally, it affects the function of exocrine glands (secondary syndrome 
Sjögren) and muscles causing sarcopenia, as well as bone osteoporosis(61–63) . 
3.3.9. Criteria of RA  
As there is no Gold Standard for the diagnosis of RA, the guidelines used over the last three years 
(2011-2014) as a basis of RA diagnosis are based on research conducted by Aletaha and his research team 
which is approved by the American College of Rheumatology (ACR), Board of Directors and the European 
League Against Rheumatism (EULAR) Executive Committee. In the new criteria set, classified as “definite RA” 
is based on the confirmed presence of synovitis in at least 1 joint, the absence of an alternative diagnosis 
that better explains the synovitis, and the achievement of a total score of 6 or greater (of a possible 10) from 
the individual scores in 4 domains: number and site of involved joints (score range 0–5), serologic 
abnormality (score range 0–3), elevated acute-phase response (score range 0–1), and symptom duration (2 
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Target population (Who should be tested?): Patients who  
1) Have at least 1 joint with definite clinical synovitis (swelling)*  
2) With the synovitis not better explained by another disease† Classification criteria for RA 
(score – based algorithm: add score of categories A – D;  
a score of ≥6/10 is needed for classification of a patient as having definite RA)‡ 
 
A. Joint involvement§  
1 large joint¶ 0 
2-10 large joints 1 
1-3 small joints (with or without involvement of large joints)# 2 
4-10 small joints (with or without involvement of large joints) 3 
>10 joints (at least 1 small joint)** 5 
B. Serology (at least 1 test result is needed for classification)††  
Negative RF and negative ACPA  0 
Low – positive RF or low – positive ACPA  2 
High – positive RF or high – positive ACPA  3 
C. Acute – phase reactants (at least 1 test result is needed for classification)‡‡  
Normal CRP and normal ESR 0 
Abnormal CRP or abnormal ESR 1 
D. Duration of symptoms§§  
<6 weeks 0 
≥6 weeks 1 
 
Table 1. The 2010 American College of Rheumatology/European League Against Rheumatism classification 
criteria for rheumatoid arthritis (64). 
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3.3.10. Quality of life 
While investigating fatigue levels and depression in patients with RA, the results showed that the 
release of a hormone called corticotrophin schetozotane, increased rates of fatigue, dysthymia, irritability 
and depression (65,66). Participants in the study reportedly had cytokines and NF -a, IL-1 and IL-6 (66). 
Furthermore, many researches show that arthritis and specifically RA has a significant impact on multiple 
dimensions of Health Related Quality Of Life (HRQOL) and Behavioural Risk Factor Surveillance System 
(BRFSS). Namely, older adults with RA reported a poorer general health, physical health, mental health, and 
sleep than their healthier counterparts. Additional, activity limitation and pain is a substantial problem 
among RA individuals compared to a healthy population (67–71). 
3.4. Exercise and RA 
A large proportion of RA patients are suffering from limited joint mobility and generally reduction of 
functionality in everyday activities. This happens due to the symptoms of the disease which are: joint 
structural damage, stiffness, pain, loss of bone density and muscle weakness (72). As a result, there is a 
significant reduction in levels of physical activity, which is combined with the fear of the patients regarding 
the aggravation of the disease. To make matters worse, health professionals still insist on limiting exercise 
for patients (73). Recent research have shown that a properly structured exercise program can achieve a 
sustained improvement in the health of patients without causing adverse effects on the activation of the 
disease and further joint damage. The main objective of an exercise program for patients with RA is to 
maintain functional capacity and improve physical fitness. 
3.4.1. Resistance Training 
Researches have already implemented resistance training programs with success in patients with RA, 
either of isometric nature of low intensity or range-of-motion exercises (74). Given the diversity of the 
disease, patients with extensive structural damage in their joints were excluded (75). However, results from 
exercise intervention studies showed an increase in function ability (76), without aggravating the feeling of 
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pain or disease activity (77). Nevertheless, it is known that the types of high intensity resistance exercise 
brings better results in increasing muscle strength in relation to the most conservative protocols, but there is 
no evidence so far with respect to deterioration of symptoms (78). In contrast, literature mentions that 
resistance exercise slows joint destruction in patients with RA (79,80) compared with those who do not 
exercise. This however, has to be further studied (81,82). 
Therefore exercise emerges as an effective and safe intervention when it is well structured and 
characterized by a progressive increase in the intensity of resistance (83). Besides the beneficial effects on 
stimulating muscle growth, it may even reverse rheumatoid cachexia (83). This is a metabolic disorder of 
unknown aetiology, subjectively affecting nearly 75% of all patients with RA and characterized by involuntary 
loss of muscle mass and progressive increase in fat mass in the presence of stable or even slightly reduced 
weight (84). 
It is a fact that non-randomisation researches, studying the effects of resistance exercise in RA, differ 
in their methodological implementation. As a result of this, a variety of different effects surface that are 
difficult to interpret. By referencing the American College of Sport Medicine (ΑCSM) guidelines (85), a 
successful exercise program with resistance in patients of advanced age that have a sedentary lifestyle, must 
include at least two sessions a week and consist of 8 to 10 exercises for the major muscle teams and consist 
of 10-15 reps for each exercise. Randomized Control Trials that followed these instructions and applied them 
to RA patients found significant differences in the improvement of functional ability (79,86,87), and muscle 
strength without affecting the existing types of structural joint damage (86,88). 
3.4.2. Aerobic training 
Patients with RA are characterized by hypo-motility which result in reduced levels of physical activity 
and capacity in comparison with corresponding healthy peers (73,89) . The following forms of exercise that 
are applied in RA studies are: 
Institutional Repository - Library & Information Centre - University of Thessaly





Cycling is an aerobic activity where muscle use is confined to the muscles of the lower extremities. 
This benefits the patients, as the body weight is not applied to the legs, making it a more accessible option. 
The opportunity presented in these applications, either in a clinical or outdoor environment, both 
individually and in groups (90), make it highly effective (91) as an intervention, even under minimum 
supervision conditions (92). Although protocols that have already been applied so far vary, it is shown that 
cycling has beneficial effects on aerobic capacity, functional capacity and muscle strength (7). 
3.4.4. Aquatic 
Due to the benefits of buoyancy, exercise in water is an ideal exercising environment for patients 
with RA (93). This view is supported by the general opinion of patients that believe that this type of exercise 
improves functional ability (94). To date, studies show that exercise in water improves aerobic capacity (95–
97), muscular strength (81,98)and the psychological status (96). 
3.4.5. Dance 
The effects of exercise through dance are highly beneficial. More specifically, improvements can be 
seen in aerobic capacity, walking ability, muscle strength (99,100)  and psychological factors such as anxiety 
and depression (99–101). 
3.4.6. Walking and Running 
Walking as an intervention has already been used for the improvement of the diseases symptoms 
(95,102,103), the assessment of functional capacity through gait analysis (104–106) and as a method of 
predicting VO2max (107) . Walking and running are included in exercise protocols for RA patients, without 
though determining the exact intensity, frequency and duration (7). 
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3.4.7 Combination of Aerobic and Strength Training 
The combination of aerobic and resistance exercise is the most widespread and effective kind of 
therapeutic workout. It produces an effective natural stimulus that helps achieve the desired physiological 
adaptations (7). Studies have shown that in recent-onset (86), active (108) or inactive RA (108) patients have 
experienced improvements in cardiorespiratory capacity and muscular strength. This lead the American 
College of Rheumatology to introduce the treatment guidelines for the management RA patients by 
implementing dynamic exercises due to their effectiveness (109).  
3.5. Maximal Oxygen Uptake (VO2max) 
The term “maximal oxygen uptake” was first used by Hill et al.(110,111) and Herbst (112) in the 
1920’s (113). VO2max (also known as functional aerobic capacity), is defined as the maximum rate of oxygen 
utilization by the exercising muscle (113,114). It is considered the "gold standard΄΄ of establishing the 
functional limitations of the cardiorespiratory system (113,114). The most objective way of measuring the 
functional aerobic capacity is the stress test. It provides useful information for assessing the physical fitness 
as well as diagnosing and determining the prognosis of ischemic heart disease (115). The results are also 
necessary for the prescription of exercise-induced cardiovascular rehabilitation programs (115). The stress 
test is considered the most accurate method for assessing the aerobic capacity and as a consequence, 
VO2max (116,117). The stress test is performed through the use of a treadmill and bicycle ergometer.  
The treadmill is a more familiar and functional way of exercise and has been shown to have a greater 
diagnostic sensitivity than the bicycle ergometer (118) . However, this method has been restricted in elderly 
people with balance problems as well as in cases such as arthritis that may cause joint pains. VO2max values 
during the bicycle ergometer test are on average 11% lower (range, 8% -15%) than those on the treadmill, 
mainly due to the participation of smaller volume of muscle mass (119–122). The VO2max value decreases as 
a person gets older (123–125). Reports show that after the third decade of ones life, the VO2max ability 
reduces by approximately 1% per year (126). This is associated with advanced age, gender, heredity and / or 
the lack of physical activity which can significantly reduce the functional capacity of an individual (exercise 
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standards), (127–129). Any further reduction of the aforementioned values can dramatically affect the 
quality of life. For instance, it will negatively affect the performance of activities in everyday life and this may 
impede the ability of one individual to live independently (128,130,131).  
The main criterion for achieving VO2max varies in the literature provided. Nevertheless, most studies 
agree on fulfilling 2 of the 3 following criteria: respiratory exchange ratio (RER) must be greater or equal to 
1.1 (132–134) , the maximum heart rate rhythm (HRmax) which can be defined by different equations (most 
known of all is the ΄΄220-age΄΄) (135,136), and  a plateau in oxygen consumption (VO2 plateau), deﬁned 
variously as an increase in oxygen uptake of 1.5 ml/min per kg (137) to 2.0 ml/min per kg (126,138). 
Furthermore, measurement of VO2max depends heavily on subjective factors such as muscle fatigue, 
perceived exhaustion, and level of motivation. Finally, the clinician’s willingness to allow participants to 
exercise to exhaustion is of crucial importance (139). 
However, most studies use young adults as samples but almost all patients are older than 70 years of 
age (140,141). The very high initial intensity and long duration of the various protocols prevent the 
successful completion of tests in older adults (142). The heart and lungs are not the only limiting factors, but 
dyspnoea (143,144), fear of overexertion (145,146), muscle weakness (143,144), lack of motivation (143) 
and the appearance of electro-cardiographic abnormalities (147) are also deterrents of a successful 
assessment. For these reasons and for patient safety, measurement of VO2max is often calculated indirectly 
by linear regression equations, relating performance to exercise VO2max (148,149). Due to the large number 
of clinical situations, many of these asymptomatic results may lead to erroneous predictions (150–152). 
3.5.1. Association of VO2max with CVD 
With regard to the cardiovascular response to exercise, Fletcher et.al defined that: ΄΄ Exercise, a 
common physiological stress, can elicit cardiovascular abnormalities not present at rest and can be used to 
determine the adequacy of cardiac function. Exercise is only one of many stresses to which humans can be 
exposed; therefore, it is more appropriate to call an "exercise" test exactly that and not a "stress test." (153) 
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There is relation between VO2max and CVD risk. The lower the VO2max value an individual has, the 
higher CVD risk possibility occurs. The first is to provide authoritative answers about the status of physical 
capacity for the patients’ health. The second is to determine the intervention, when required, as well as for 
prevention CVD (153). 
The main clinical signs of CVD include the risk of arrhythmia, myocardial damage (which is reflected 
by the left ventricular function) and the degree of myocardium in jeopardy. With regard to the risk of 
arrhythmia, the stress test is the only diagnostic method, given the close relationship with abnormalities of 
the left ventricle. Relative to myocardial ischemia, clinical symptoms during the stress test includes angina, 
ST segment depression and ST segment elevation over ECG areas without Q waves (diagnostic agents of the 
heart through the use of electrocardiogram). However, it is difficult to predict the amount of ischemia (153).  
Finally, the VO2max test also helps in determining prognosis in symptomatic. Namely, post-
myocardial infarction patients, patients with stable CAD (including silent ischemia), patients having done a 
Coronary Artery Bypass Surgery (CABS), and patients who had undergone percutaneous transluminal 
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Similarities Between Atherosclerosis and Rheumatoid Arthritis 
 Atherosclerosis Rheumatoid Arthitis 
Macrophage activation   
TNFα ↑ ↑ 
Metalloproteinase expression 
↑ ↑ 
Interleukin-6 ↑ (UA) ↑ 
Mast-cell activation ↑ ↑ 
T-cell activation   
Soluble IL2 receptor ↑ (UA) ↑ 
CD3+DR+ ↑ (UA) ↑ 
CD4+CD28- ↑ (UA) ↑ 
CD4+IFNγ+ ↑ (UA) ↑ 
Th1/Th2 balance ↑ Th1 ↑ Th1 
B-cell activation   
Autoantibodies (oxLDL, HSP) 
0 OR ↑ 0 OR ↑ 
Rheumatoid factor 0 ↑ 
C-reactive protein ↑ (UA) ↑↑ 
Adhesion molecules (VCAM-1, 
ICAM-1, E-selectin, P-selectin) 
↑ ↑ 
Endothelin ↑ ↑ 
Neoangiogenesis ↑ ↑ 
Possible antigens 
HSP, 0x-LDL, Infectious agents 
Collagen II, Cartilage antigens, 
HSP, Infectious agents 
 
Table 2.Pasceri V, Yeh E. A tale of two diseases atherosclerosis and rheumatoid arthritis. Circulation. 1999  
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3.5.2. VO2max IN RA 
Patients with RA exhibit reduced levels of cardiorespiratory endurance (CRF) (73). High levels of CRF 
protect against cardiovascular disease mortality, (155,156) the presence of cardiovascular risk factors, 
(157,158) and CRF levels associated with low levels of inflammation (159). 
The CRP gene is associated with factors (160,161) that can be significantly increased with training 
regardless of age, gender, race, and initial fitness levels. (162,163). Patients with increased fitness levels are 
hospitalized less often and for less time as opposed to inactive patients (164). Therefore, exercise may help 
to improve cardiovascular risk and the overall health status of patients with RA (8). However, although 
relevant research has already proved the importance of exercise in patients with RA, during this literature 
review, there is no study that examines the stress test results in this population. This is to do with 
observational restrictions on the realization of a true VO2max test. Given the characteristics of chronic 
inflammation and joint pains, it is highly possible for these people to stop the test, not because of 
cardiorespiratory limitation but due to other factors associated with the pathophysiology of the disease. This 
leads to inaccurate results and incorrect prescription of the exercise program. As a result, patients will not 
get all the benefits of exercise and thus, the risk of future cardiovascular disease remains high. 
3.5.3. Exercise in RA and Physical Function 
Exercise improves a wide variety of objective physical function tests, including assessments of 
balance and co-ordination, grip strength, the jump-high test, various different sub-maximal or maximal 
aerobic fitness tests, and tests designed to reflect the ability to perform activities of daily living (e.g. 30 sec 
sit-to-stand; 8’ up & go; 30 sec arm-curl; 50’ walk) (165) . Moreover, these beneficial effects are highlighted 
in two Cochrane reviews confirming that high-intensity aerobic and/or resistance exercise significantly 
improves physical function in patients with RA [18, 20]. In fact, a promising find in a study by Lemmey et 
al.(165) revealed that although baseline patients’ physical function was significantly poorer (≈ 20-30%) than 
age and sex-matched norms, a 24-week high-intensity exercise intervention was sufficient to restore normal 
physical function in RA patients with long-standing disease. It is also important to note that these benefits 
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are recognized by patients. In support of this, studies reveal significant improvements in subjective function, 
such as self-reported fatigue and the McMaster Toronto Arthritis Disability Questionnaire 
(MACTAR)(83,166–169).  
These are indeed very promising findings and support the use of “exercise as medicine” in RA. Giles 
and his colleagues have demonstrated that the increased adiposity and reduced muscle mass, both 
independently, predict a poorer self-assessed physical function (Health Assessment Questionnaire; HAQ) in 
RA patients (170) .  it is believed that the effects of high-intensity exercise on physical function are partly 
mediated by exercise-induced beneficial alterations in body composition. Studies directly investigating this 
assumption are currently lacking. 
3.5.4. Exercise in RA and Body Composition 
In RA patients, resistance training alone has been found to significantly increase muscle mass 
(83,165) probably due to the increased muscle levels of insulin-like growth factor-I that coincided with the 
hypertrophic response to resistance training (165). Combining resistance and aerobic training also results in 
increases in the muscle cross-sectional area of type I and II fibers in RA patients, even within six weeks, 
(167,171) while significant improvements in electromyographic activity and quadriceps femoris cross-
sectional area are evident after 21 weeks (172). These findings are in line with the strengthening and 
hypertrophic responses seen in healthy individuals following appropriate exercise training (173). In fact, 
Hakkinen et al. has directly compared women with RA with age-matched healthy women and showed 
comparable absolute and relative increases in strength as well as similar increases in quadriceps femoris 
thickness and reductions in quadriceps femoris subcutaneous fat thickness following the completion of the 
same combined strength and aerobic training programme (172).  This similarity in the training response is 
consistent with reports that muscle quality (i.e. muscle architecture, specific force, and voluntary activation 
capacity) is maintained in RA despite reductions in muscle quantity (174).  
Along with increases in muscle mass, significant exercise-induced reductions in fat mass are evident 
in RA patients(83,165,172). It is of particular interest that high intensity exercise may decrease trunk fat up 
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to 2.5kg (83,165) which may improve the arterial stiffening in RA patients (175) and therefore, reduce the 
risk for CVD (176) . In a recent study, Stavropoulos-Kalinoglou et al.(8) showed that a combined aerobic and 
strength exercise intervention increased VO2max, and that this increase was the sole predictor of reduced 
fat mass.  
But how can these significant exercise-induced body composition alterations ameliorate disease 
activity and severity in RA? The answer to this lies in the acute and chronic effects of exercise on the 
function and structure of both the musculoskeletal system and adipocytes. The contracting (exercising) 
muscle stimulates cellular immune changes that have a significant anti-inflammatory effect. More 
specifically, exercise-induced muscle-derived interleukin 6 (IL-6), which is predominantly described as a pro-
inflammatory cytokine in RA, may exert an anti-inflammatory and immunosuppressive effect with a down-
regulating impact on the acute phase response (177) as well acting as a signal for replenishing depleted 
muscle glycogen stores (178). Acute exercise also expresses anti-inflammatory effects with increased levels 
of anti-inflammatory cytokines such as IL-10 and IL-1 receptor antagonist (174). These phenomena may have 
a profound effect on the cytokine profile and, thus, inflammatory response in RA patients in whom the 
disease-driven overexpression of these cytokines leads to increased disease activity and severity. In addition, 
amongst the long term effects of exercise are increased muscle mass, balance and co-ordination which have 
a beneficial impact on physical function and thus, disease severity (179). With regards to the effects of 
exercise on adipocytes, it is accepted that exercise reduces inflammation via the inhibition of adipocyte-
derived pro-inflammatory cytokines and improvement in adipocyte oxidative capacity (180). The latter may 
also be linked with the significant reduction in the cardiovascular risk of RA patients as a result of exercise 
(3,181).    
3.5.5. Exercise in RA and Cardiovascular Risk 
It is well established that RA associates with an increased risk for CVD, with cardiovascular events 
typically occurring approximately a decade earlier in RA patients compared to the general population (182). 
This may be partly due to the increased prevalence of hypertension [69, 70], hypercholesterolemia 
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(183,184), vascular dysfunction (5,185) and insulin resistance (186,187) seen in RA patients. In addition, the 
significant inflammation-induced alterations in body composition (rheumatoid cachexia) have been 
implicated in this increased CVD risk (6,9). However, all these factors collectively can only partly explain the 
increased CVD risk in RA. This suggests that an interplay of these factors with other parameters may exist 
which contribute to this increased prevalence of CVD in RA.           
One such parameter is exercise. Lack of exercise and/or physical activity can result in low CRF a 
major CVD risk factor (188). Metsios et al., (189) demonstrated that physical inactivity in RA, associated with 
an inferior cardiovascular profile in RA, characterized by exacerbations of both classical and novel CVD risk 
factors. It appears, however, that high-intensity aerobic and resistance exercise can reverse this 
phenomenon. Results from a recent trial revealed that such an intervention significantly ameliorated blood 
pressure, body fat the lipid profile, vascular function and markers of oxidative stress, and the10-year CVD 
event probability of RA patients   (190–192). Interestingly, the increase in CRF was the strongest predictor 
for each of these observed improvements. This observation is consistent with effects seen in the general 
population, with meta-analyses revealing  that increased CRF leads to improvements in blood pressure (193), 
high-density lipoprotein (HDL) levels (194) ,  insulin resistance and body fat (195). 
The reasons why high-intensity exercise has such profound effects on the cardiovascular profile in 
RA, warrants further investigation in appropriately designed trials. However, in patients with RA, exercise-
induced reductions in fat mass were independently associated with the improvements seen in blood 
pressure as well as in inflammatory biomarkers (181).  So again, the significant exercise-induced changes in 
body composition may account for this. Therefore, it seems that exercise holds a significant promise in 
improving the cardiovascular profile of RA patients.  
 
Institutional Repository - Library & Information Centre - University of Thessaly






RA patients attending routine clinics of the Department of Rheumatology, Russell’s Hall Hospital, 
Dudley Group NHS Foundation Trust, Research and Development (RND), UK, were approached.  
4.2. Inclusion Criteria 
In this research, RA (1987 ACR criteria) patients can participate which have been diagnosed in the 
past 10 years, without co-morbidities prohibiting.  
4.3. Exclusion Criteria 
Exclusion factors from the study are cases of patients with extended joint pain who are unable to 
participate in an increased physical activity test as well as cases suffering from a secondary disease that 
prevents them from an evaluation of the maximal oxygen uptake. 
4.4. Study design 
4.4.1. General Procedures 
The trial was registered with the ISRCTN register. All assessments were conducted within the clinical 
research unit of Research and Development of Russell’s Hall Hospital, Dudley Group NHS Foundation Trust. 
During the arranged appointment and after a detailed description of the procedures involved, all patients 
were asked to sign a consent form. 
4.4.2. Assessments 
4.4.2.1. Anthropometric Characteristics 
Demographic data was collected using a self-administered questionnaire. Weight, body fat and fat-
free mass wαs evaluated using a Tanita BC-418. Analyser (Tokyo, Japan) and the height (Leicester height 
measure).  
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4.4.2.2. Cardiorespiratory ﬁtness 
All participants (105) were subjected to an Exercise Tolerance Test (ETT) on a mechanical treadmill 
(HP Cosmos Mercury, Nussdorf-Traunstein, Germany). CRF was determined on the basis of maximal oxygen 
uptake (VO2max) using a calibrated breath-by-breath system (Metalyzer 3B, CORTEX, Leipzig, Germany). An 
individualised ramp test protocol, based on the guidelines of the American Heart Association (24) was used. 
These protocols are more suitable to clinical settings than protocols using large intervals or steps (25). 
Testing started at a convenient speed for the participants (in most cases 2.0-3.5 mph) and 1% inclination. 
Speed increased at a perceived brisk walking rhythm by 2.0 mph until 3 min. Thereafter, inclination of the 
treadmill would increase every 1 min by 1,5 %. Testing was terminated when the participant reached final 
exhaustion. 
4.4.2.3. Disease Activity Score 28  
Disease activity was measured with the use of DAS28 (Prevoo et al. 1995). This is a composite 
assessment consisting of the patient’s assessment of overall health during the last week on a visual analogue 
scale, a 28 joint count and the current ESR. To identify the swollen and tender joints, the nurse had to 
squeeze the joints of the arms, elbows, hand and knees (Appendix 3) of every participant.    
4.4.2.4. Functional Capacity 
The anglicised version of the 40-item Stanford Health Assessment Questionnaire (HAQ), (Kirwan and 
Reeback 1986) was used to measure functional disability. In this assessment, participants rate their ability 
(over the past week) to carry out 20 activities within eight aspects of daily living (dressing/grooming, rising, 
eating, walking, hygiene, reach, grip and errands/tasks) on a four-point scale from ‘without any difficulty’ to 
‘unable to do’ (Appendix 4). For each aspect, patients also responded whether they received assistance from 
people or used specific devices. The HAQ is internally consistent (α ≥ 0.89) and has excellent pre to post-
physician visit temporal stability (r = 0.99). 
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5. Statistics  
We used descriptive statistics to record specific variables such as age, BMI, VO2max, HAQ and DAS 
28. 
Independent samples T-test we used to assess the differences between those who achieved the 
established VO2max criteria and those who did not in terms of HAQ and DAS 28. All analysis conducted via 







































































































Table 3. Statistics of VO2MAX, Disease Activity Score 28 (DAS28) and Disease Severity (HAQ). 
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9.947 1 9.947 1.630 0.205 
Within 
Groups 
494.377 81 6.103 
  
Total 504.324 82 




0.890 1 0.890 3.991 0.049 
Within 
Groups 
21.860 98 0.223 
  
Total 22.750 99 
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  Mean Std. Deviation 
Age A 
Male 59.00 9.959 
Female 52.51 12.816 
Total 54.53 12.328 
VO2max 
Male 21.8812 5.60930 
Female 19.1603 4.38660 
Total 20.0074 4.93823 
Height 
Male 1.7652 0.08675 
Female 1.6336 0.06423 
Total 1.6745 0.09418 
Weight 
Male 86.030 15.8669 
Female 76.044 18.8324 
Total 79.153 18.4799 
BMI_t1 
Male 27.5881 4.69595 
Female 28.3118 6.18531 
Total 28.0865 5.75049 
 
Table 5: Statistics between groups and anthropometric characteristics. 
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Table 6: Significance between groups and anthropometric characteristics. 
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From the 105 patients who participated in the present study, 73 were women (69.5%) and 32 were 
men (30.5 %). The average age of the participants was 54.6±12.3 years (52.4±12.8 for women and 59.5±9.9 
men). BMI average ratio was 28.2 (women BMI average ratio was 28±6.1 and men 27.5±4.6), which belongs 
to the overweight category with regard to World Health Organization (WHO) (reference). Of the 105 
patients, only 28 out of all (percentage of 26.6 %) managed to meet two of three criteria for a successful CRF 
test (achieved plateau, RER > 1.1 and HRmax > 220-age). Specifically, 7 were men (success rate 29.1%) and 
21 females (28.8% success rate). About VO2 plateau, only 5 (4 women and 1 man) out of 105 patients 
reached a plateau, having the very poor percentage of success of 4.7%. With regards to RER, the success 
ratio was 82 patients (78%), with 59 of them being women (percentage of 80.2%) and 23 were men 
(percentage of 71.8%). Relatively to HRmax, the total successful number was 29 patients (percentage of 
27.6%) with 8 men (percentage of 25%) and 21 women (percentage of 28.7 %). 
 
 
Figure 1: Study characteristics-VO2 Max criteria  
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Figure 2: VO2 Max criteria by female  
 
 
Figure 3: VO2 Max criteria by male  
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Figure 5: Differences in Disease Severity between groups 
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To our knowledge, this is the ﬁrst study that investigates the criteria for a true maximal CRF test in 
RA. We found that only 26.6 % of the patients managed to perform a successful VO2max assessment. 
Therefore, this is a very small percentage of patients that achieved the criteria of VO2max testing, indicating 
that 74.4% of RA patients did not achieve cardiorespiratory exhaustion. Moreover, with regard to the 
statistical analysis, patients that achieved VO2max had better results in HAQ. Additionally, since there was no 
significant difference in DAS 28 evaluation, the outcome indicates the importance of functional ability on 
performing such types of testing, but not inflammation, given the lack of significant differences between 
VO2max and DAS28. This is something that is proved for the first time in contradiction to what was believed 
until today. Having the above results, it is indicated that further research should be focused so as to improve 
the patient’s functional ability. During the research of the current literature, there are no published studies 
targeting to increase the functional ability in RA patients before the initial CRF assessment. Although, 
Lemmey et al revealed, that although baseline patients’ physical function was significantly poorer (≈ 20-30%) 
than age- and sex-matched norms, a 24-week high-intensity exercise intervention was sufficient to restore 
normal physical function in RA patients with long-standing disease. Thus, we suggest that exercise 
prescription development should include an individualised aerobic programme during the first 4 weeks 
before the initial VO2max testing. Given the beneficial results of exercise in RA and of other chronic diseases, 
it seems reasonable to suggest that ΄΄exercise can be used as medicine ΄΄. As such, it is very important to 
prescribe the specific exercise level, just like it is done with prescription medication. Consequently, 
optimization of exercise prescription is going to gain the biggest benefits, while significantly reducing the 
high risk of CVD.  
The limitations that occurred in our study were two. There were patients without any previous 
experience in exercise and more specifically, walking on a treadmill. Although we did an induction session on 
the treadmill for 5 minutes for our patients to become familiar with the process before the test. Additionally, 
recruited patients with better functional ability and positive bias did not participate in this study. 
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This study demonstrates that the results of RA patient’s during the initial CRF assessment, driven to 
VO2peak and not VO2max (26.6 % success rate). Even more, this is not due to the disease activity of RA 
causing the extended joint inflammation, but because of the disease severity. Further research is required to 
determine the exact mechanisms behind these phenomena, particularly if the improvement of functional 
ability before the initial assessment, which can lead to a true VO2max test. As a result, exercise prescription 
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9. Recommendations  
Exercise has multiple health benefits for RA patients, supporting the use of “exercise as medicine” in 
RA. The different training programmes and modes utilised in the literature along with the reported 
attendance rates indicate that patients with RA can safely perform different types of high intensity exercise 
programmes, and enjoy the same range and magnitude of benefits as age and sex-matched healthy 
individuals.    
To achieve and maintain the significant benefits of exercise, apart from following established 
training progression principles (196), specific attention needs to be given to devising tailored programmes 
for these patients because RA can differently affect each patient. Along with this, it is also important to 
understand the patients’ preferences in order to devise an effective exercise programme. This will very likely 
increase adherence to regular structured physical activity and reduce the sedentary behaviours seen in RA 
(197). We suggest the following specific principles for exercising in RA: 
1. Using existing infrastructure and/or a home-based approach (where possible), exercise should be 
part of the overall management of RA in combination with pharmacological and behavioural 
interventions.     
2. The main targets of exercise in RA should be initially to restore functional ability with the intention 
to initiate exercise programmes that aim the improvement of CVD risk as well as disease 
activity/severity which seem to depend on exercise-induced changes in body composition. 
3. The development of exercise programmes for RA patients will need to take into account: a) the 
ACSM relative and absolute contra-indications for exercise testing as well as the risk stratification 
algorithms for increasing the safety of exercise participation (198) and b) baseline fitness levels, 
functional ability and personal preferences. 
4. Exercise prescription development should include an aerobic mainly programme during the first 4 
weeks, followed by a combined high-intensity aerobic and resistance training intervention, as the 
later seems to improve more both function and cardiovascular profile in RA.  
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For these suggestions to take effect, it seems peremptory that the rheumatology specialists need to 
enhance their knowledge on exercise in RA and rectify their opinions about the benefits of exercise. 
Interventions that target these factors need to be the focus of future research. Importantly, new courses 
that educate and provide the practical skills for the development of exercise programmes for exercise 
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11.2. Consent Form 
Informed consent form for participation in a research study. 
11.2.1. Title of the Study 
Examination of the Exercise Tolerance Test results for the VO2max established criteria of patients with RA. 
11.2.2. Aim of the Study 
The major purpose of this study is to evaluate the criteria for successful VO2max in patients with RA. This will 
lead us to an optimization of the exercise prescription in order to minimize the possibility of cardiovascular 
disease in the future. 
11.2.3. Description of Research Activities 
This research consists of a VO2max test. It is carried out in Russell's Hall Hospital, West Midlands, Dudley 
Group of Hospitals NHS Trust at the Research and Development (RND) center. In charge of the test will be an 
exercise physiologist leading the procedure and a cardiac physiologist responsible for the Electrocardiogram. 
At the beginning, the blood pressure, height, weight, body fat and fat-free mass will be evaluated. 
Afterwards, in order for the Electrocardiogram procedure to take place, the cardiac physiologist will place 
patches on your breast (in front of your heart) and the exercise physiologist will place a gas analyzer mask on 
your face. Initially, you will sit for two minutes on a chair with the mask on your face in order to get used to 
it. Next, you will step on the treadmill to begin with the test by doing a warm up for two minutes at 1% 
gradient at approximately your normal walking speed. Then, for the following two minutes we will increase 
the gradient of the treadmill at 3.0% and the walking rhythm from a comfortable to a brisk walking level for 
you. Keeping this rhythm, we will only change the gradient by 1.5% for every minute until your request to 
end and supposed that you have achieved your maximal capacity. In any case, if you experience any 
symptoms, discomfort or for any reason you want to stop the test, we shall do so immediately. At the end of 
the assessment, you will have a sit again on the chair for two minutes in order to recover with the mask on 
your face and repeated blood pressure measurements will be done in order to ensure that you have been 
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calmed down. When your blood pressure is the same as that of when you arrived, you will be able to leave 
the hospital.   
11.3   Risks/ Discomfort Involved 
The VO2max test stresses the body and as a result, some side effects may occur such as leg and general 
fatigue, dizziness, shortness of breath and exercise induced hypotension. Moreover, before and after the 
test you need to get some rest. Finally, the researchers and the hospital staff are there to guarantee your 
safety, as that is our prime priority. 
11.3.1. Expected Impact 
Because of the extended joint inflammation, a side effect of RA is inactivity, the most predominant risk 
factor for CVD. The latest research reports the strong relation of CVD and RA and the benefits of exercise. 
Nonetheless, there is no research that investigates weather cardiorespiratory limitations are responsible for 
the discontinuation of the test, or if other factors are responsible. The aim of this study is to investigate the 
above in order to achieve an optimized exercise prescription program and minimise the possibility of CVD in 
the future for RA patients. 
11.3.2. Dissemination of Results 
All research projects belong to the Group of Hospitals, NHS Trust, and all participating patients are subject to 
ethical review through the NHS National Research Ethics System. The research team has extensive 
experience in these processes for projects of varying nature and complexity in clinical populations. This 
includes ethical approval for clinical and basic science data storage and analysis, obtaining biomaterials, 
long-term storage, and medical publication, collaborations with industry and inclusion or exclusion of future 
commercial use. The project will be conducted in accordance with the Research Governance Framework for 
Health and Social Care. All participants will provide their informed, written consent and be aware that their 
details will be stored in a coded fashion on a secured database with restricted and governed access. In 
particular, patients will be informed and consented that their data might be used in academic collaborations. 
Institutional Repository - Library & Information Centre - University of Thessaly




In addition, they will be made aware that they are under no obligation to participate and can withdraw at 
any point without providing a reason.      
11.4. Further Information 
Do not hesitate to make questions regarding the aim of this study or the implementation of study design. If 
you have any doubts or questions, do ask us for clarifications. 
11.4.1. Freedom of Consent 
You are a volunteer participant. You are free to withdraw your consent now or later.   
11.4.2. Participant’s declaration 
I read this form and I understand the procedures involved. I agree to participate in this study. 
   
Date: __/__/__ 
 
[Name and signature of participant] 
 
 [Name and signature of 
researcher] 
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11.5. Disease Activity Score 28 (DAS28)   
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11.6. Disease Severity (HAQ) 
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11.6. Copyright Statement 
 
Υπεύθυνη Δήλωση 
Η κάτωθι υπογεγραμμένη NAME μεταπτυχιακή/ος φοιτήτρια/ης του Προγράμματος Μεταπτυχιακών 
Σπουδών «ΑΣΚΗΣΗ ΚΑΙ ΥΓΕΙΑ» του Τμήματος Επιστήμης Φυσικής Αγωγής και Αθλητισμού  του 
Πανεπιστημίου Θεσσαλίας 
 δηλώνω υπεύθυνα ότι αποδέχομαι τους παρακάτω όρους που αφορούν  
(α) στα πνευματικά δικαιώματα της Μεταπτυχιακής Διπλωματικής Εργασίας (ΜΔΕ) μου με τίτλο 
«Maximal oxygen uptake in Rheumatoid Arthritis»  
 (β) στη διαχείριση των ερευνητικών δεδομένων που θα συλλέξω στην πορεία εκπόνησής της: 
1. Τα πνευματικά δικαιώματα του τόμου της μεταπτυχιακής διατριβής που θα προκύψει  θα 
ανήκουν σε μένα. Θα ακολουθήσω τις οδηγίες συγγραφής, εκτύπωσης και κατάθεσης αντιτύπων της 
διατριβής στα ανάλογα αποθετήρια (σε έντυπη ή/και σε ηλεκτρονική μορφή).  
2. Η διαχείριση των δεδομένων της διατριβής ανήκει από κοινού σε εμένα και στον/στην πρώτο 
επιβλέποντα -ουσα καθηγητή -τριας.  
3. Οποιαδήποτε επιστημονική δημοσίευση ή ανακοίνωση (αναρτημένη ή προφορική), ή 
αναφορά που προέρχεται από το υλικό/δεδομένα της εργασίας αυτής θα γίνεται με συγγραφείς 
εμένα τον ίδιο, τον/την κύριο-α επιβλέποντα -ουσα  ή και άλλους ερευνητές (όπως πχ μέλους –ών της 
τριμελούς συμβουλευτικής επιτροπής), ανάλογα με τη συμβολή τους στην έρευνα ή στη συγγραφή 
των ερευνητικών εργασιών.  
4. Η σειρά των ονομάτων στις επιστημονικές δημοσιεύσεις ή επιστημονικές ανακοινώσεις θα 
αποφασίζεται από κοινού από εμένα και τον/την κύριο -α επιβλέποντα -ουσα της εργασίας,  πριν 
αρχίσει η εκπόνησή της. Η απόφαση αυτή θα πιστοποιηθεί εγγράφως μεταξύ εμού και του/της κ. 
επιβλέποντα -ουσας. 
Τέλος, δηλώνω ότι γνωρίζω τους κανόνες περί λογοκλοπής και πνευματικής ιδιοκτησίας και ότι θα 
τους τηρώ απαρέγκλιτα καθ’ όλη τη διάρκεια της φοίτησης και κάλυψης των εκπαιδευτικών 
υποχρεώσεων που προκύπτουν από το ΠΜΣ/τμήμα, αλλά και των διαδικασιών δημοσίευσης που 
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